A2 Biotherapeutics

Innovating New Treatments for Solid Tumors

Agoura Hills, United States · Founded 2018 · $208.5M raised

Founded
2018
Business Model
B2B
Website
a2bio.com
Total Funding
$208.5M
Last Round
$80.0M Series CJan 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

A2 Biotherapeutics is a clinical-stage cell therapy company developing first-in-class logic-gated CAR T-cell therapies for solid tumors using its proprietary Tmod technology platform. Founded in 2018 by Alexander Kamb, Michael Gallo, and Paul Kang, the company is headquartered in Agoura Hills, California, and is advancing multiple T-cell programs targeting cancers with unmet need.

Summary

A2 Biotherapeutics is a Biotech company based in Agoura Hills, United States, founded in 2018. It has raised $208.5M in total across 3 rounds, most recently a $80.0M Series C round in Jan 2025. Investors include Nextech Invest, Vida Ventures and Section 32.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries C2025 (est.)
$80.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

A2 Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/a2-biotherapeutics"><img src="https://indexed.vc/api/badge/company/a2-biotherapeutics" alt="A2 Biotherapeutics on Indexed.vc" width="260" height="76" /></a>